# International HIV Antiretroviral Adherence, Resistance and Survival

> **NCT01596322** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 750 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01596322
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596322, "International HIV Antiretroviral Adherence, Resistance and Survival". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01596322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*